首页> 美国卫生研究院文献>Journal of Cellular and Molecular Medicine >miR24‐2 accelerates progression of liver cancer cells by activating Pim1 through tri‐methylation of Histone H3 on the ninth lysine
【2h】

miR24‐2 accelerates progression of liver cancer cells by activating Pim1 through tri‐methylation of Histone H3 on the ninth lysine

机译:miR24-2通过第九个赖氨酸上的组蛋白H3的三甲基化激活Pim1来加速肝癌细胞的进程

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Several microRNAs are associated with carcinogenesis and tumour progression. Herein, our observations suggest both miR24‐2 and Pim1 are up‐regulated in human liver cancers, and miR24‐2 accelerates growth of liver cancer cells in vitro and in vivo. Mechanistically, miR24‐2 increases the expression of N6‐adenosine‐methyltransferase METTL3 and thereafter promotes the expression of miR6079 via RNA methylation modification. Furthermore, miR6079 targets JMJD2A and then increased the tri‐methylation of histone H3 on the ninth lysine (H3K9me3). Therefore, miR24‐2 inhibits JMJD2A by increasing miR6079 and then increases H3K9me3. Strikingly, miR24‐2 increases the expression of Pim1 dependent on H3K9me3 and METTL3. Notably, our findings suggest that miR24‐2 alters several related genes (pHistone H3, SUZ12, SUV39H1, Nanog, MEKK4, pTyr) and accelerates progression of liver cancer cells through Pim1 activation. In particular, Pim1 is required for the oncogenic action of miR24‐2 in liver cancer. This study elucidates a novel mechanism for miR24‐2 in liver cancer and suggests that miR24‐2 may be used as novel therapeutic targets of liver cancer.
机译:几种microRNA与癌变和肿瘤进展有关。在本文中,我们的观察结果表明,miR24-2和Pim1在人肝癌中均上调,而miR24-2在体外和体内均可加速肝癌细胞的生长。从机制上讲,miR24-2会增加N6-腺苷甲基转移酶METTL3的表达,然后通过RNA甲基化修饰促进miR6079的表达。此外,miR6079靶向JMJD2A,然后增加第九个赖氨酸(H3K9me3)上组蛋白H3的三甲基化。因此,miR24-2通过增加miR6079然后增加H3K9me3来抑制JMJD2A。令人惊讶的是,miR24-2增加了依赖于H3K9me3和METTL3的Pim1的表达。值得注意的是,我们的发现表明miR24-2可以改变几个相关基因(pHistone H3,SUZ12,SUV39H1,Nanog,MEKK4,pTyr),并通过Pim1激活加速肝癌细胞的进程。特别是,miR24-2在肝癌中的致癌作用需要Pim1。这项研究阐明了miR24-2在肝癌中的新机制,并建议将miR24-2用作肝癌的新型治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号